Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • News

Medical Devices Player AngioDynamics Exceeds Q1 Expectations, Sticks To Annual Guidance

By Vandana Singh
October 4, 2:09 PM
AngioDynamics Inc (NASDAQ: ANGO) has reported a Q1 FY24 adjusted EPS loss of $(0.12), beating the consensus of $(0.13) but higher than $(0.06) reported a year ago.</

ANGO

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Movers
  • News

Novartis Shares Decline As Spin Off Sandoz’s Market Debut Falls Short of Expected Valuation

By Vandana Singh
October 4, 12:35 PM
Sandoz Group AG (OTC: SDZNY) (OTC: SDZXF) enters a new era as a standalone player in generic and biosimilar medicines.

NVS

Read More
1 minute read
  • General
  • Health Care
  • News

Kaiser Permanente Workers Start 3 Day-Strike, Possibly Largest Healthcare Strike In US History

By Vandana Singh
October 4, 10:39 AM
Over 75,000 employees of Kaiser Permanente initiated a three-day strike, posing a significant threat to one of the nation's largest healthcare providers and contributing to the ongoing labor disruptions sweeping across various US industries. 

SPY

Read More
1 minute read
  • Contracts
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks

Why Sleep Disorder Focused Vivos Therapeutics Stock Trading Higher Today?

By Vandana Singh
October 4, 10:36 AM
Vivos Therapeutics Inc (NASDAQ: VVOS) announced two critical strategic agreements that will expand Vivos' current product line and are expected to create near-term 

VVOS

Read More
2 minute read
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Pfizer’s Diversity Program Faces Legal Heat, Advocacy Group Revives Discrimination Case

By Vandana Singh
October 4, 10:25 AM
Advocacy group Do No Harm has made a case before the New York-based 2nd U.S.

PFE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks

Why Is Gene Therapy Player Freeline Therapeutics Stock Trading Higher Today?

By Vandana Singh
October 4, 10:23 AM
Freeline Therapeutics Holdings plc (NASDAQ: FRLN) reported initial data from the ongoing Phase 1/2 GALILEO-1 trial of FLT201, its adeno-associated virus (AAV) gene therapy candidate, 

FRLN

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Johnson & Johnson Sees Legal Win In Talc Powder Cancer Claims

By Vandana Singh
October 4, 8:51 AM
A New Jersey appeals court overturned a $223.8 million verdict linked to asbestos exposure in Johnson & Johnson's (NYSE: JNJ) 

JNJ

Read More
2 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People

By Vandana Singh
October 4, 8:47 AM
Sanofi SA (NASDAQ: SNY) and Teva Pharmaceutical Industries Ltd (NYSE: TEVA) have collaborated to co-develop and 

SNY

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • FDA
  • General
  • Health Care
  • News

Is Amgen’s Lung Cancer Drug Lumakras Up to the Mark? FDA Briefing Raises Concerns

By Vandana Singh
October 3, 3:30 PM
The FDA released briefing documents ahead of Oncologic Drugs Advisory Committee meeting scheduled for October 5 to review Amgen Inc's (NASDAQ:

AMGN

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • M&A
  • News
  • Rumors

Novartis Mulls Divesting Some Assets Of Radiopharma Unit In Strategic Shift

By Vandana Singh
October 3, 2:20 PM
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) is reportedly contemplating selling sections of radiopharmaceuticals company Advanced Accelerator Applications to align with the company's strategy and the broader industry trend to shed low-growth segments.

BLCO

Posts pagination

Previous 1 … 148 149 150 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service